Preferred Ready‑to‑Use Holo‑Transferrin for Industrial‑Grade Procurement
2026-05-20
Recombinant Transferrin (Holo‑Form) ART202S
Preferred Ready‑to‑Use Holo‑Transferrin for Industrial‑Grade Procurement
With years of experience in biopharmaceutical raw‑material supply, we fully understand real‑world pain points faced by thousands of pharmaceutical enterprises and CDMOs in procurement and mass production: long lead times, inflexible pricing and unstable supply of imported raw materials; high compliance risks and inconsistent batch quality of traditional animal‑derived feedstocks; time‑consuming iron‑ion adjustment for self‑developed culture media; and extra costs from frequent restocking caused by short shelf‑life limits for inventory.
Based on practical front‑line customer demands, our company strongly recommends Recombinant Transferrin (Holo‑Form) ART202S. Boasting four core strengths — compliance stability, ready‑to‑use convenience, high cost‑effectiveness and long‑term stocking suitability — it provides a one‑stop solution for full‑chain challenges including enterprise procurement, process deployment, regulatory filing and long‑term mass production. It is the optimal domestic iron‑carrier alternative to imported products, helping cut costs and boost production efficiency.
Four Practical Values Addressing Core Production & Procurement Requirements
Animal‑Free Compliance Protection, Avoiding Rework Costs for Regulatory Filings
Produced via Pichia pastoris genetic recombination, the product contains no serum, plasma or other animal‑derived components, fundamentally eliminating contamination risks of mycoplasma and blood‑borne viruses. Fully meeting global regulatory standards such as NMPA and FDA requirements, it requires no extra safety verification for exogenous factors and can be directly used for IND filings and commercial production, saving substantial time and capital spent on compliance rectification and repeated validation.
ART202S features a fixed holo‑saturated structure with precise, consistent iron‑ion ratios. Ready‑to‑use with no iron‑concentration adjustment needed, it directly adapts to large‑scale serum‑free and low‑serum culture systems. It greatly minimizes formula variables, prevents fluctuations in cell viability and target‑product expression during process scale‑up, shortens process validation cycles, frees up R&D manpower and accelerates core project progress.
With purity ≥98.0% (HPLC‑RP), the dry powder dissolves quickly and maintains stable activity. Manufactured under standardized GMP quality control, it delivers excellent batch‑to‑batch consistency. Stored in sealed, light‑proof conditions at 2‑8 °C, it has a 5‑year shelf life, supporting bulk centralized procurement to reduce extra expenses from scattered or rush orders. With flexible specifications and clear MOQ, it offers outstanding cost‑effectiveness for bulk purchases and fits medium‑to‑long‑term production planning.
Wide Compatibility with All Cell Platforms, Directly Boosting Production Output & Profitability
Perfectly compatible with mainstream production systems including CHO cells, CAR‑T cells, stem cells and primary cells, it fully retains the bioactivity of human transferrin to efficiently supply iron nutrition and protect cells against oxidative stress. It effectively increases cell expansion density and raises expression levels of target products such as antibodies and recombinant proteins, directly helping enterprises expand production capacity and lower unit production costs.
Grade: Cell Culture Grade / Industrial Production Grade
Purity: ≥98.0% (HPLC‑RP)
Standard Packaging: 1g, 10g, 100g; kilogram‑scale customized mass production available
Minimum Order Quantity (MOQ): ≥100g
Storage: Sealed and protected from light at 2‑8 °C, 5‑year shelf life
Applications: Industrial‑scale antibody drug production, CAR‑T cell preparation, stem‑cell R&D, commercial vaccine mass manufacturing, large‑scale serum‑free medium application
Cooperation Guarantee | Front‑Line Supply for Trouble‑Free Deployment
As the sales team, we prioritize stable on‑time delivery of in‑stock products, offering customized packaging, bulk price negotiation and formula‑matching technical support on demand. Free from premium pricing and supply risks of imported raw materials, it enables enterprises to achieve independent control of core raw materials with reliable domestic quality, truly delivering hassle‑free procurement, stable production, full regulatory compliance and long‑term cost reduction.
Anrate ART202S is a pragmatic choice for biopharmaceutical enterprises pursuing large‑scale mass production and global market expansion.
Important Notice
This product is intended solely for scientific research, laboratory and production purposes. It is not for clinical treatment and shall not be used on animals or humans.